Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +90.1% | -12.0% | 1 / 3 | -19.5% | -14.94 pp | +11.42 pp | +29.3% | 0.05 | 2.96 | 198 | −19,5% | 39,4 | +88,9% | 2.96 | 2.94 | +0,5% |
| Pts | 12 | 0 | 4 | 0 | 0 | 12 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 6.410 (close price on 2026-10-19)EPS (TTM): 2.169
Financial charts
1.Revenue & growth
VND bn198Q2/26
1.Revenue & growth
VND bn198Q2/26
2.Profit & growth
VND bn39,1Q2/26
3.Profit mix (Penman)
VND bn118Q2/26
4.Margins & cost structure
%23.2%Q2/26
5.Returns & cash cycle
% · days16.2%Q2/26
6.Earnings quality & cash
VND bn-10,4Q2/26
7.Asset structure
VND bn2.742Q2/26
8.Funding & debt health
VND bn · times2.742Q2/26
9.Revenue backlog
VND bn92,8Q2/26
10.Valuation
times · %3,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %765Q2/26
Adjusted EPS growth, latest quarter
90.1%
Average adjusted EPS growth, 3 quarters
-12.0%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26